These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24359145)

  • 1. Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome.
    Ni J; Ma X; Zhou M; Pan X; Tang J; Hao Y; Lu Z; Gao M; Bao Y; Jia W
    Cardiovasc Diabetol; 2013 Dec; 12():176. PubMed ID: 24359145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated circulating lipocalin-2 levels independently predict incident cardiovascular events in men in a population-based cohort.
    Wu G; Li H; Fang Q; Jiang S; Zhang L; Zhang J; Hou X; Lu J; Bao Y; Xu A; Jia W
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2457-64. PubMed ID: 25189569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease.
    Sahinarslan A; Kocaman SA; Bas D; Akyel A; Ercin U; Zengin O; Timurkaynak T
    Coron Artery Dis; 2011 Aug; 22(5):333-8. PubMed ID: 21558855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery Disease.
    Oberoi R; Bogalle EP; Matthes LA; Schuett H; Koch AK; Grote K; Schieffer B; Schuett J; Luchtefeld M
    PLoS One; 2015; 10(9):e0137924. PubMed ID: 26367277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating level of lipocalin 2 as a predictor of severity in patients with community-acquired pneumonia.
    Yeh YH; Chang JL; Hsiao PC; Tsao SM; Lin CH; Kao SJ; Chou MC; Yang SF; Chien MH
    J Clin Lab Anal; 2013 Jul; 27(4):253-60. PubMed ID: 23852780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipocalin-2 levels are increased in patients with psoriasis.
    Kamata M; Tada Y; Tatsuta A; Kawashima T; Shibata S; Mitsui H; Asano Y; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S
    Clin Exp Dermatol; 2012 Apr; 37(3):296-9. PubMed ID: 22300286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum levels of lipocalin-1 and -2 in patients with stable chronic obstructive pulmonary disease.
    Wang XR; Li YP; Gao S; Xia W; Gao K; Kong QH; Qi H; Wu L; Zhang J; Qu JM; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():543-9. PubMed ID: 24920892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.
    Shen Y; Ma X; Zhou J; Pan X; Hao Y; Zhou M; Lu Z; Gao M; Bao Y; Jia W
    Cardiovasc Diabetol; 2013 Aug; 12():124. PubMed ID: 23981342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between subclinical cardiovascular disease and lipocalin-2 levels in women with PCOS.
    Gencer M; Gazi E; Hacıvelioğlu S; Binnetoğlu E; Barutçu A; Türkön H; Temiz A; Altun B; Vural A; Cevizci S; Kumcular T; Coşar E
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():99-103. PubMed ID: 25145761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA.
    Stejskal D; Karpísek M; Humenanska V; Hanulova Z; Stejskal P; Kusnierova P; Petzel M
    Horm Metab Res; 2008 Jun; 40(6):381-5. PubMed ID: 18393169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neutrophil gelatinase-associated lipocalin levels are correlated with the complexity and the severity of atherosclerosis in acute coronary syndrome.
    Soylu K; Aksan G; Nar G; Özdemir M; Gülel O; İnci S; Aksakal A; Soylu Aİ; Yılmaz Ö
    Anatol J Cardiol; 2015 Jun; 15(6):450-5. PubMed ID: 25430410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome.
    Dong B; Ji W; Zhang Y
    Intern Med; 2011; 50(10):1093-7. PubMed ID: 21576834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Lipocalin 2 Levels Predict Fracture-Related Hospitalizations in Elderly Women: A Prospective Cohort Study.
    Lim WH; Wong G; Lim EM; Byrnes E; Zhu K; Devine A; Pavlos NJ; Prince RL; Lewis JR
    J Bone Miner Res; 2015 Nov; 30(11):2078-85. PubMed ID: 25939604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome.
    El-Hadidi H; Samir N; Shaker OG; Otb S
    Arch Dermatol Res; 2014 Apr; 306(3):239-45. PubMed ID: 24052155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipocalin-2 levels in pregnant women with pre-eclampsia, and their relation with severity of disease.
    Cemgil Arikan D; Ozkaya M; Adali E; Kilinc M; Coskun A; Ozer A; Bilge F
    J Matern Fetal Neonatal Med; 2011 Feb; 24(2):291-6. PubMed ID: 20504246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people.
    Huang Y; Yang Z; Ye Z; Li Q; Wen J; Tao X; Chen L; He M; Wang X; Lu B; Zhang Z; Zhang W; Qu S; Hu R
    Cardiovasc Diabetol; 2012 Jan; 11():11. PubMed ID: 22292925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma levels of lipocalin 2 in mild cognitive impairment.
    Choi J; Lee HW; Suk K
    J Neurol Sci; 2011 Jun; 305(1-2):28-33. PubMed ID: 21463871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum pigment epithelium-derived factor levels are independently correlated with the presence of coronary artery disease.
    Wang F; Ma X; Zhou M; Pan X; Ni J; Gao M; Lu Z; Hang J; Bao Y; Jia W
    Cardiovasc Diabetol; 2013 Apr; 12():56. PubMed ID: 23547730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer-based Sandwich Assay and its Clinical Outlooks for Detecting Lipocalin-2 in Hepatocellular Carcinoma (HCC).
    Lee KA; Ahn JY; Lee SH; Singh Sekhon S; Kim DG; Min J; Kim YH
    Sci Rep; 2015 Jun; 5():10897. PubMed ID: 26039737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status.
    Stallhofer J; Friedrich M; Konrad-Zerna A; Wetzke M; Lohse P; Glas J; Tillack-Schreiber C; Schnitzler F; Beigel F; Brand S
    Inflamm Bowel Dis; 2015 Oct; 21(10):2327-40. PubMed ID: 26263469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.